publication venue for
- Caution regarding interpretation of trends for the global burden of atopic dermatitis and asthma. 2025
- Complex comorbidities: could a diabetes drug help prevent atopic dermatitis?. 193:5-6. 2025
- Atopic dermatitis, cognitive function and psychiatric comorbidities across early childhood and adolescence in a population-based UK birth cohort.. 190:501-509. 2024
- Atopic dermatitis and risk for headache disorders and migraines: a population-based cohort study in children and adults from the UK.. 190:120-123. 2023
- Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatment.. 189:339-341. 2023
- Malignancy risk in patients with atopic dermatitis: a population-based cohort study.. 189:53-61. 2023
- Atopic dermatitis across the life course.. 188:709-717. 2023
- Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.. 188:12-21. 2023
- Qualitative analysis of the impact of atopic dermatitis on caregivers and the quantitative impact of atopic dermatitis on caregivers across multiple life domains.. 187:1038-1041. 2022
- The quantitative impact of atopic dermatitis on caregivers across multiple life domains.. 187:1041-1043. 2022
- Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.. 187:271-273. 2022
- Age- and Sex- Adjusted Prevalence Estimates Among Pediatric Patients with Psoriasis in the United States.. 187:270-271. 2022
- COVID-19 outcomes in patients with autoimmune blistering disease.. 185:1048-1050. 2021
- Ingenol mebutate 0·015% gel is safe for short-term treatment of actinic keratoses on the face in solid organ transplant recipients.. 183:575-577. 2020
- A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients.. 175:1073-1075. 2016